Civic Intelligence

Cohen Veterans Bioscience Inc.

990 • Fiscal year 2023 • EIN 47-1981973

Jul 01, 2022 to Jun 30, 2023 • Filed on Nov 14, 2023

535 8th Avenue 12th FloorNew York, NY 10018

(646) 970-4325

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

64th percentile

0.33x

Higher debt load relative to assets than 64% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Liabilities / Revenue

58th percentile

0.34x

Higher debt load relative to revenue than 58% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Net Margin

9th percentile

-35%

Higher net margin than 9% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Top Officer Pay

92nd percentile

$565,735

Higher top officer pay than 92% of similar nonprofits.

Top officer pay equals 5.0% of source-year revenue.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2023

Asset Growth

3rd percentile

-25%

Faster asset growth than 3% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2022 to 2023

Revenue Growth

10th percentile

-37%

Faster revenue growth than 10% of similar nonprofits.

2023 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2022 to 2023

Assets

Down

$11,743,398

Down $3,843,953 (-25%) from 2022

Net Assets

Down

$7,889,693

Down $3,997,832 (-34%) from 2022

Liabilities

Up

$3,853,705

Up $153,879 (+4.2%) from 2022

Revenue

Down

$11,343,534

Down $6,738,864 (-37%) from 2022

Expenses

Down

$15,341,366

Down $2,182,418 (-12%) from 2022

Net Income

Down

-$3,997,832

Down $4,556,446 (-816%) from 2022

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$30M$20M$10M$0-$10MAssets 2015: $450,595Liabilities 2015: $326,443Net Assets 2015: $124,1522015Assets 2016: $25,419,016Liabilities 2016: $10,161,873Net Assets 2016: $15,257,1432016Assets 2017: $14,863,415Liabilities 2017: $6,579,459Net Assets 2017: $8,283,9562017Assets 2018: $16,353,364Liabilities 2018: $6,020,527Net Assets 2018: $10,332,8372018Assets 2019: $24,190,269Liabilities 2019: $12,988,921Net Assets 2019: $11,201,3482019Assets 2020: $18,865,456Liabilities 2020: $8,431,760Net Assets 2020: $10,433,6962020Assets 2021: $17,952,584Liabilities 2021: $6,826,523Net Assets 2021: $11,126,0612021Assets 2022: $15,587,351Liabilities 2022: $3,699,826Net Assets 2022: $11,887,5252022Assets 2023: $11,743,398Liabilities 2023: $3,853,705Net Assets 2023: $7,889,6932023Assets 2024: $3,075,275Liabilities 2024: $3,105,844Net Assets 2024: -$30,5692024Assets 2025: $1,835,419Liabilities 2025: $98,368Net Assets 2025: $1,737,0512025

Highlighted filing

2023

Assets$11,743,398
Liabilities$3,853,705
Net Assets$7,889,693

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MRevenue 2015: $70,035Expenses 2015: $651,553Net Income 2015: -$581,5182015Revenue 2016: $31,399,759Expenses 2016: $16,266,768Net Income 2016: $15,132,9912016Revenue 2017: $4,366,629Expenses 2017: $11,339,816Net Income 2017: -$6,973,1872017Revenue 2018: $16,845,541Expenses 2018: $14,796,660Net Income 2018: $2,048,8812018Revenue 2019: $21,039,448Expenses 2019: $20,170,937Net Income 2019: $868,5112019Revenue 2020: $16,470,665Expenses 2020: $18,162,920Net Income 2020: -$1,692,2552020Revenue 2021: $16,252,270Expenses 2021: $18,110,420Net Income 2021: -$1,858,1502021Revenue 2022: $18,082,398Expenses 2022: $17,523,784Net Income 2022: $558,6142022Revenue 2023: $11,343,534Expenses 2023: $15,341,366Net Income 2023: -$3,997,8322023Revenue 2024: $8,377,751Expenses 2024: $14,079,910Net Income 2024: -$5,702,1592024Revenue 2025: $3,369,809Expenses 2025: $1,377,761Net Income 2025: $1,992,0482025

Highlighted filing

2023

Revenue$11,343,534
Expenses$15,341,366
Net Income-$3,997,832
Jump To
Filing Snapshot
Filing Period
Jul 1, 2022 to Jun 30, 2023
Signed
Nov 14, 2023
Return Version
2022v5.0
Gross Receipts
$11,343,534
Mission and Program Overview

Mission

Cohen veterans bioscience is the only 501(c)3 non-profit research organization with a singular focus on ptsd and tbi research. We are dedicated to fast-tracking the development of diagnostic tests and personalized medicines for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain.

Biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$3,831,713$5,471,810▲ $1,640,097
Land, Buildings, and Equipment, Net$1,432,920$1,967,457▲ $534,537
Pledges and Grants Receivable$8,295,108$1,762,522▼ $6,532,586
Cash and Non-Interest-Bearing Accounts$999,648$828,606▼ $171,042
Prepaid Expenses and Deferred Charges$123,073$98,344▼ $24,729
Accounts Receivable$21,300--
Total Assets$15,587,351$11,743,398▼ $3,843,953
Other Assets Total$883,589$1,614,659▲ $731,070
Liabilities
Accounts Payable and Accrued Expenses$2,682,753$1,818,611▼ $864,142
Other Liabilities$139,342$1,294,809▲ $1,155,467
Deferred Revenue$740,285$740,285→ $0
Grants Payable$137,446--
Total Liabilities$3,699,826$3,853,705▲ $153,879
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$7,257,190$5,480,842▼ $1,776,348
Net Assets With Donor Restrictions$4,630,335$2,408,851▼ $2,221,484
Total Net Assets Fund Balance$11,887,525$7,889,693▼ $3,997,832
Total Liabilities and Net Assets / Fund Balance$15,587,351$11,743,398▼ $3,843,953

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$1,826,934$373,112$2,200,046
Equipment$74,997$99,079$174,076
Leasehold Improvements$65,526$68,836$134,362
Other Assets Org$415,451--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Magali Haas Md PhdCEO & PresidentFT$473,560$92,175$565,735
Allyson Gage PhdChief Medical OfficerFT$384,589$119,782$504,371
Amanda Nicole HarmonChief Operations OfficerFT$283,405$117,761$401,166
Lee LancashireChief Information OfficerFT$310,941$57,367$368,308
Evgeny RakhmatulinChief Technology OfficerFT$241,822$102,694$344,516
Maryan ZirkleExecutive Director, BraincFT$238,362$68,663$307,025
Mark ZervasDeputy Director, TranslatiFT$188,176$65,171$253,347
Lauren GoldsmithSenior Director, ContractsFT$227,944$24,610$252,554
Renee DavisExecutive Director, DeveloFT$208,434$18,344$226,778
Peter HoehnExecutive VP, Marking Strategy, Develop, & ImpactFT$183,750-$183,750
Peter HoehnExecutive VP, Marking Strategy, Deve-$141,346$42,404$183,750
Andrew ThompsonAssociate Director, Data ScienceFT$159,579$18,005$177,584

Board Members and Trustees

NameTitle
Dave DemarcoBoard Member
David BiondiBoard Member
Theresa FrangiosaSecretary
Michael SullivanTreasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Waveaccess USAProvide Resources For Brain Commons And10161 WEST RUN PARK DRIVE SUITE 15, Las Vegas, NV 89145$596,186
Iconic Event Studios INCEvent Coordination1861 SUNSET PLAZA DRIVE, Los Angeles, CA 90069$477,417
Hitachi Vantara LLCRean And Bc2535 AUGUSTINE DRIVE, Santa Clara, CA 95054-3003$420,000
Grf Cpa's & AdvisorsAccounting Services4550 MONTGOMERY AVENUE SUITE 800 N, Bethesda, MD 20814$342,803
Tone Creative LLCMarketing And Design Services63 PUTNAM STREET SUITE 202, Sarasota Springs, NY 12866$273,270
Revenue and Support

Revenue Composition

Contributions and Grants
$10,755,381
Program Service Revenue
$0
Investment Income
$223,966
Other Revenue
$364,187
All Other Contributions
$10,755,381
Change in Net Assets
$-3,997,832

Audited Revenue Reconciliation

Revenue per Audited Statements
$11,343,534
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$11,343,534
Total Revenue per Form 990
$11,343,534
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$8,383,425
Salaries, Compensation, and Employee Benefits$6,759,744
Total Fundraising Expense$430,116
Grants and Similar Amounts Paid$198,197
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$4,584,048$222,134$21,188$4,827,370
Other Salaries and Wages$2,798,978$178,570$194,367$3,171,915
Current Officers, Directors, Trustees, and Key Employees$2,461,672$136,427$150,001$2,748,100
Occupancy$500,366$24,560$63$524,989
Information Technology$510,664$5,049$2,429$518,142
Office Expenses$319,644$169,622$7,706$496,972
Travel$441,230$17,090$3,161$461,481
Fees for Services Accounting$6,320$408,678-$414,998
Depreciation Depletion$340,599$2,097$2,291$344,987
Other Employee Benefits$304,762$16,524$18,025$339,311
Fees for Services Legal$229,420$88,480-$317,900
Payroll Taxes$284,374$15,503$16,945$316,822
Conferences and Meetings$249,121$2,775-$251,896
Pension Plan Contributions$164,976$8,912$9,708$183,596
Fees for Services Lobbying$120,000--$120,000
Grants to Domestic Orgs$108,171--$108,171
Insurance$71,023$29,435$4,232$104,690
Foreign Grants$90,026--$90,026
Total Functional Expenses$13,585,394$1,325,856$430,116$15,341,366

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$15,341,366
Total Expenses per Audited Statements$15,341,366
Total Expenses per Form 990$15,341,366
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
University of California San DiegoLa Jolla, CA501(c)3ALCOHOL-PTSD COMORBIDITY: PRECLINICAL STUDIES$108,171

International Summary

Offices
0
Employees
0
Spending
$90,026

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland) - Albania, Andorra, Austria, BelgiumGrants to Recipients Located in RegionN/a00$90,026
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Operating Lease Liability$1,294,809
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

The form 990 was reviewed by the organization's outsourced cfo and then reviewed, authorized and signed by the organization's ceo & president.

Form 990, Part VI, Section B, Line 12C

The board of directors requires an annual declaration from all board members and senior management as to the existence and disclosure of any potential conflicts of interest. The board members sign a disclosure statement. Any potential conflicts are discussed by the dis-interested board members, while the party in potential conflict is required to leave the room. Board meeting minutes will document the discussion and decision making process. In the event of a potential conflict, procedures to obtain competitive bids and diligence on fair market value will be established.

Form 990, Part VI, Section B, Line 15

Cvb's executive compensation program is administered by the board of directors. The board is responsible for establishing and maintaining a competitive compensation program for the key executives of the organization. The board meets as needed to review the compensation program and make recommendations for any changes, as appropriate. A performance evaluation is conducted and reviewed each year and is intended to ensure that the compensation program falls within a reasonable range of competitive practices for comparable positions among similarly situated organizations. Following this review, the board reviews and approves, for selected key executives, base salaries and annual incentive opportunity adjustments, and objectives and goals upcoming year's annual incentive plan. The board reviews and recommends to the board salary approval and incentive awards for the ceo/president and selected key senior staff.

Form 990, Part VI, Section C, Line 19

Upon request and forms available through charity navigator website as well.

Filing and Contact Details

Filer

Filer Name
Cohen Veterans Bioscience Inc
EIN
47-1981973
Phone
6469704325
Address
535 8TH AVENUE 12TH FLOOR, NEW YORK, NY 10018

Signing Officer

Name
Magali Haas Md Phd
Title
CEO & President
Phone
6469704325
Signed
2023-11-14
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Magali Haas Md Phd
Formed
2014
Legal Domicile
Ma
Voting Board Members
5
Independent Board Members
4
Employees
36
Volunteers
50

Preparer

Firm
Smith Sullivan & Brown Pc
Address
80 FLANDERS ROAD - SUITE 302, WESTBOROUGH, MA 01581
Preparer
Sandra M Brown CPA
Phone
5088717178
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

Other professional fees: program service expenses 0. Management and general expenses 183,849. Fundraising expenses 0. Total expenses 183,849. Research collaboration expenses: program service expenses 597,783. Management and general expenses 0. Fundraising expenses 0. Total expenses 597,783. Contracted services: program service expenses 3,986,265. Management and general expenses 38,285. Fundraising expenses 21,188. Total expenses 4,045,738.

Financial Statement Notes

PART X, LINE 2:

Tax position: the organization currently evaluates all tax positions and makes a determination regarding the likelihood of those positions being upheld under review. The primary tax position made by the organization is the existence of unrelated business income tax and the organization's status as a tax-exempt public charity under irc section 501(c)(3). For the year presented, the organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on this evaluation.

Raw XML AppendixShowing 400 of 876 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt02682753
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt01818611
IRS990/AccountsReceivableGrp/BOYAmt021300
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.
IRS990/AllOtherContributionsAmt010755381
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0GELMAN ROSENBERG AND FREEDMAN CPA
IRS990/BooksInCareOfDetail/PhoneNum03019519090
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt04550 MONTGOMERY AVENUE SUITE 650N
IRS990/BooksInCareOfDetail/USAddress/CityNm0BETHESDA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020814
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0999648
IRS990/CashNonInterestBearingGrp/EOYAmt0828606
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt020
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt0150001
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0136427
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt02461672
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt02748100
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt02775
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0249121
IRS990/ConferencesMeetingsGrp/TotalAmt0251896
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt0596186
IRS990/ContractorCompensationGrp/CompensationAmt1477417
IRS990/ContractorCompensationGrp/CompensationAmt2420000
IRS990/ContractorCompensationGrp/CompensationAmt3342803
IRS990/ContractorCompensationGrp/CompensationAmt4273270
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt010161 WEST RUN PARK DRIVE SUITE 15
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt11861 SUNSET PLAZA DRIVE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt22535 AUGUSTINE DRIVE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt34550 MONTGOMERY AVENUE SUITE 800 N
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt463 PUTNAM STREET SUITE 202
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0LAS VEGAS
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1LOS ANGELES
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm2SANTA CLARA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm3BETHESDA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm4SARASOTA SPRINGS
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0NV
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd2CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd3MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd4NY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd089145
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd190069
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd2950543003
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd320814
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd412866
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0WAVEACCESS USA
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1ICONIC EVENT STUDIOS INC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2HITACHI VANTARA LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt3GRF CPA'S & ADVISORS
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt4TONE CREATIVE LLC
IRS990/ContractorCompensationGrp/ServicesDesc0PROVIDE RESOURCES FOR BRAIN COMMONS AND
IRS990/ContractorCompensationGrp/ServicesDesc1EVENT COORDINATION
IRS990/ContractorCompensationGrp/ServicesDesc2REAN AND BC
IRS990/ContractorCompensationGrp/ServicesDesc3ACCOUNTING SERVICES
IRS990/ContractorCompensationGrp/ServicesDesc4MARKETING AND DESIGN SERVICES
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt010755381
IRS990/CYGrantsAndSimilarPaidAmt0198197
IRS990/CYInvestmentIncomeAmt0223966
IRS990/CYOtherExpensesAmt08383425
IRS990/CYOtherRevenueAmt0364187
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-3997832
IRS990/CYSalariesCompEmpBnftPaidAmt06759744
IRS990/CYTotalExpensesAmt015341366
IRS990/CYTotalFundraisingExpenseAmt0430116
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt011343534
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0740285
IRS990/DeferredRevenueGrp/EOYAmt0740285
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt02291
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt02097
IRS990/DepreciationDepletionGrp/ProgramServicesAmt0340599
IRS990/DepreciationDepletionGrp/TotalAmt0344987
IRS990/Desc0BRAIN HEALTH TOOLS & TECHNOLOGIES:IN ORDER TO FAST-TRACK PRECISION DIAGNOSTICS AND TARGETED THERAPEUTICS AND WELLNESS APPROACHES FOR MAINTENANCE AND RESTORATION OF BRAIN HEALTH, CVB IS LEVERAGING INNOVATION AND TECHNOLOGY TO BUILD TOOLS AND PLATFORMS THAT ENABLE DISCOVERY AND DEVELOPMENT ACROSS BRAIN DISEASES. THESE TOOLS & PLATFORMS ALLOW RESEARCHERS FROM ACADEMIA AND INDUSTRY TO ACCESS AND UTILIZE BEST-IN-CLASS PRACTICES AND ALLOW EFFORTS TO BE SCALED WITH RIGOR AND REPRODUCIBILITY.(SEE SCHEDULE O FOR FULL DETAIL OF OUR PROGRAMS)PLATFORM EFFORTS FOCUS ON CAPACITY THAT ENABLES RELIABLE DISCOVERY OF BIOMARKERS AND BIOLOGICAL PATHWAYS THAT ARE TRANSLATIONALLY RELEVANT FOR THE DEVELOPMENT OF DIAGNOSTICS AND THERAPEUTIC TARGETS FOR DRUG AND OTHER MEDICAL INTERVENTIONS. EACH PLATFORM IS CREATING RESEARCH TOOLS (E.G. ANIMAL MODELS, DATA STANDARDS, COMPUTATIONAL MODELS, REFERENCE DATABASES, ETC.) THAT WILL ACCELERATE/FOSTER THESE DISCOVERIES.WITHIN THIS FRAMEWORK, CVB HAS ESTABLISHED BOTH INTRAMURAL (RESEARCH CONDUCTED BY, OR INCLUDING, CVB STAFF OR CONTRACTORS) AND EXTRAMURAL RESEARCH PROGRAMS (RESEARCH CONDUCTED VIA GRANTS OR IN COLLABORATION WITH EXTERNAL ACADEMIC, INDUSTRY, FOUNDATION AND GOVERNMENT PARTNERS) AND ALSO OPERATES SEVERAL PUBLIC-PRIVATE PARTNERSHIPS. THESE COOPERATIVE ALLIANCES ORGANIZE AND FUND A NETWORK OF PARTNERS WHO EACH CONTRIBUTE COMPLEMENTARY AND SYNERGISTIC DATA, CAPABILITIES, OR EXPERTISE TO SUPPORT A COMMON ROADMAP FOR IDENTIFYING DIAGNOSTIC BIOMARKERS, BUILDING PREDICTIVE BRAIN DISEASE MODELS, DEVELOPING ROBUST STANDARDIZED TRANSLATIONAL TOOLS, AND CATALYZING PHARMACEUTICAL DRUG DEVELOPMENT. THE EMPHASIS IS ON TEAM SCIENCE WITH COHEN VETERANS BIOSCIENCE SERVING AS ITS HUB.OUR PLATFORM PROGRAMS CURRENTLY INCLUDE THE BRAINCOMMONS (CLOUD-BASED DATA & ANALYTICS), EARLYSIGNAL (WEARABLE AND HOME SENSORS FOR MONITORING HEALTH STATUS), RAPID-DX (ESTABLISHING BEST PRACTICES FOR DISCOVERY AND VALIDATION OF BIOMARKERS), AMP-IT-UP (FOR PRECLINICAL DISCOVERY AND TRANSLATION) AND TAP (TARGET ADVANCEMENT PROGRAM).BRAINCOMMONS:THE BRAINCOMMONS (BC) IS A CLOUD-BASED RESEARCH AND DISCOVERY PLATFORM FOR THE BRAIN HEALTH COMMUNITY WHICH FEATURES DATA, TOOLS, AND COMMUNITY ACCESS IN A SECURE, SCALABLE, AND SUSTAINABLE ENVIRONMENT. IT IS DESIGNED TO FURTHER DEMOCRATIZE DATA AND ENABLE GREATER COLLABORATION GLOBALLY AMONG BRAIN SCIENTISTS WORKING IN A VARIETY OF SETTINGS.WE ARE IN A NEW ERA OF BRAIN RESEARCH, WHERE POWERFUL DATA ACQUISITION TECHNOLOGIES ARE GENERATING MULTIMODAL DATA AT INCREASING SCALES. TO ENABLE DISEASE MODELING EFFORTS, AS WELL AS THE DISCOVERY AND REPLICATION OF BIOMARKERS, THERE IS A CRITICAL NEED FOR A PLATFORM THAT CAN HOUSE MULTI-MODAL DATA TYPES, ACROSS DIAGNOSTIC CATEGORIES, IN CONJUNCTION WITH DATA PIPELINES TO ENSURE REPRODUCIBLE ANALYSIS, AND WITH AN ABILITY TO APPLY STATE-OF-THE ART MACHINE-LEARNING ALGORITHMS. IN 2022, THE BRAINCOMMONS WAS LAUNCHED TO OUR FIRST COMMUNITY OF RESEARCH PARTNERS IN PTSD, TBI AND PARKINSON'S.IN 2023, WE HAVE LAUNCHED A NEW USER INTERFACE FOR THE BRAINCOMMONS AND HAVE UPLOADED OUR NATIONAL NORMATIVE NEUROIMAGING LIBRARY DATA TO THE PLATFORM TO BE SHARED WITH THE RESEARCH COMMUNITY WITH ACCOMPANYING PIPELINES FOR DATA PROCESSING.EARLYSIGNAL:THE AIM OF OUR DIGITAL HEALTH PROGRAM, EARLY SIGNAL, IS TO RECORD AND ANALYZE A RANGE OF DATA DIRECTLY RELATED TO THE WELL-BEING OF PATIENTS LIVING WITH BRAIN DISORDERS. BEHAVIORAL, COGNITIVE, PHYSIOLOGICAL AND OTHER INFORMATION ARE COLLECTED THROUGH OUR INTEGRATED TECHNOLOGY PLATFORM.WEARABLE AND SENSOR TECHNOLOGIES HOLD PROMISE IN THE ASSESSMENT AND CONTINUOUS MONITORING OF PATIENTS IN ORDER TO BETTER SCREEN AND DIAGNOSE, MONITOR DISEASE PROGRESSION, AND OBSERVE INTERVENTION RESPONSE OR LACK THEREOF. DIGITAL HEALTH MONITORING ALSO ALLOWS US TO STUDY BRAIN HEALTH AND DISEASE IN UNPRECEDENTED WAYS, BY TRACKING VARIABLES SUCH AS SLEEP, PHYSICAL ACTIVITY, STRESS AND COGNITION, WE MAY BE ABLE TO BETTER UNDERSTAND WHAT CHANGES OVER TIM
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd01
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt04630335
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt02408851
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt036
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt013585394
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0408678
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt06320
IRS990/FeesForServicesAccountingGrp/TotalAmt0414998
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt088480
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0229420
IRS990/FeesForServicesLegalGrp/TotalAmt0317900
IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt0120000
IRS990/FeesForServicesLobbyingGrp/TotalAmt0120000
IRS990/FeesForServicesOtherGrp/FundraisingAmt021188
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0222134
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt04584048
IRS990/FeesForServicesOtherGrp/TotalAmt04827370
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt090026
IRS990/ForeignGrantsGrp/TotalAmt090026
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt19.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1440.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt018300
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt557367
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt622635
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt736449
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt838944
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1022610
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1136101
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1225337
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1318344
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1418005
IRS990/Form990PartVIISectionAGrp/PersonNm0MAGALI HAAS MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm1THERESA FRANGIOSA
IRS990/Form990PartVIISectionAGrp/PersonNm2MICHAEL SULLIVAN
IRS990/Form990PartVIISectionAGrp/PersonNm3DAVID BIONDI
IRS990/Form990PartVIISectionAGrp/PersonNm4DAVE DEMARCO
IRS990/Form990PartVIISectionAGrp/PersonNm5LEE LANCASHIRE
IRS990/Form990PartVIISectionAGrp/PersonNm6ALLYSON GAGE PHD
IRS990/Form990PartVIISectionAGrp/PersonNm7AMANDA NICOLE HARMON
IRS990/Form990PartVIISectionAGrp/PersonNm8EVGENY RAKHMATULIN
IRS990/Form990PartVIISectionAGrp/PersonNm9PETER HOEHN
IRS990/Form990PartVIISectionAGrp/PersonNm10LAUREN GOLDSMITH
IRS990/Form990PartVIISectionAGrp/PersonNm11MARK ZERVAS
IRS990/Form990PartVIISectionAGrp/PersonNm12MARYAN ZIRKLE
IRS990/Form990PartVIISectionAGrp/PersonNm13RENEE DAVIS
IRS990/Form990PartVIISectionAGrp/PersonNm14ANDREW THOMPSON
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0547435
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5310941
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt6481736
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7364717
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt8305572
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9183750
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10229944
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11217246
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12281688
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13208434
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt14159579
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO & PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5CHIEF INFORMATION OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt6CHIEF MEDICAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt7CHIEF OPERATIONS OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt8CHIEF TECHNOLOGY OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt9EXECUTIVE VP, MARKING STRATEGY, DEVELOP, & IMPACT
IRS990/Form990PartVIISectionAGrp/TitleTxt10SENIOR DIRECTOR, CONTRACTS
IRS990/Form990PartVIISectionAGrp/TitleTxt11DEPUTY DIRECTOR, TRANSLATI
IRS990/Form990PartVIISectionAGrp/TitleTxt12EXECUTIVE DIRECTOR, BRAINC
IRS990/Form990PartVIISectionAGrp/TitleTxt13EXECUTIVE DIRECTOR, DEVELO
IRS990/Form990PartVIISectionAGrp/TitleTxt14ASSOCIATE DIRECTOR, DATA SCIENCE
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantAmt0198197
IRS990/GrantsPayableGrp/BOYAmt0137446
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0108171
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0108171
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt011343534
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt020
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt02429
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt05049
IRS990/InformationTechnologyGrp/ProgramServicesAmt0510664
IRS990/InformationTechnologyGrp/TotalAmt0518142
IRS990/InsuranceGrp/FundraisingAmt04232
IRS990/InsuranceGrp/ManagementAndGeneralAmt029435
IRS990/InsuranceGrp/ProgramServicesAmt071023
IRS990/InsuranceGrp/TotalAmt0104690
IRS990/InvestmentIncomeGrp/ExclusionAmt0223966
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0223966
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt032
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0541027
IRS990/LandBldgEquipBasisNetGrp/BOYAmt01432920
IRS990/LandBldgEquipBasisNetGrp/EOYAmt01967457
IRS990/LandBldgEquipCostOrOtherBssAmt02508484
IRS990/LegalDomicileStateCd0MA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0COHEN VETERANS BIOSCIENCE, INC. IS A NON-PROFIT 501(C)(3) BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt011887525
IRS990/NetAssetsOrFundBalancesEOYAmt07889693
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt07257190
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt05480842
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt063
IRS990/OccupancyGrp/ManagementAndGeneralAmt024560
IRS990/OccupancyGrp/ProgramServicesAmt0500366
IRS990/OccupancyGrp/TotalAmt0524989
IRS990/OfficeExpensesGrp/FundraisingAmt07706
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0169622
IRS990/OfficeExpensesGrp/ProgramServicesAmt0319644
IRS990/OfficeExpensesGrp/TotalAmt0496972
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0883589
IRS990/OtherAssetsTotalGrp/EOYAmt01614659
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt018025
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt016524
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0304762
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0339311
IRS990/OtherLiabilitiesGrp/BOYAmt0139342
IRS990/OtherLiabilitiesGrp/EOYAmt01294809
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/BusinessCd1900099
IRS990/OtherRevenueMiscGrp/Desc0GRANT REFUNDS
IRS990/OtherRevenueMiscGrp/Desc1OTHER REFUNDS
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt0326982
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt137205
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt0326982
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt137205
IRS990/OtherRevenueTotalAmt0364187
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt0194367
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0178570
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt02798978
IRS990/OtherSalariesAndWagesGrp/TotalAmt03171915
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt016945
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt015503
IRS990/PayrollTaxesGrp/ProgramServicesAmt0284374
IRS990/PayrollTaxesGrp/TotalAmt0316822
IRS990/PensionPlanContributionsGrp/FundraisingAmt09708
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt08912
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt0164976
IRS990/PensionPlanContributionsGrp/TotalAmt0183596
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt08295108
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt01762522
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0123073
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt098344
IRS990/PrincipalOfficerNm0MAGALI HAAS MD PHD
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0THE STATE OF THE SCIENCE SUMMITS ARE THE BASIS FOR BUILDING THE ROADMAPS AND ARE DESIGNED AS RETREATS FOR 100 TO 200 STAKEHOLDERS TO COME TOGETHER TO REALIZE TRUE IMPACT. THE STAKEHOLDERS ENCOMPASS A BROAD SWATH OF THE COMMUNITY FROM ACADEMIC INSTITUTIONS TO GOVERNMENT AGENCIES, FOUNDATIONS SUPPORTING TRANSLATIONAL RESEARCH, INDUSTRY AND INDIVIDUALS WITH LIVED EXPERIENCE.EACH SUMMIT SERVES AS A LAUNCHPAD FOR ONGOING WORKING GROUPS TO DEVELOP EVIDENCE-BASED STRATEGIES AND RECOMMENDATIONS ON HOW TO FILL THOSE GAPS, IDENTIFY NEW GAPS AS OTHERS ARE FILLED, AND DISSEMINATE THESE FINDINGS BACK TO THE COMMUNITY AT LARGE THROUGH WHITE PAPERS AND PROCEEDINGS.THE INAUGURAL STATE OF THE SCIENCE SUMMIT ("SOSS"), HELD IN 2018, FOCUSED ON DIAGNOSIS OF TRAUMA-RELATED BRAIN DISORDERS WITH A MAJOR FOCUS ON POST-TRAUMATIC STRESS DISORDER. THE TRAUMA-RELATED BRAIN DISORDERS RESEARCH COMMUNITY HAS IDENTIFIED A NEED TO ESTABLISH A MECHANISM-BASED TAXONOMY FOR THESE CONDITIONS TO ADVANCE BIOMARKER DISCOVERY AS WELL AS DIAGNOSIS AND THERAPEUTIC DEVELOPMENT. A SHIFT FROM A SYNDROMIC CLASSIFICATION SYSTEM TO A MECHANISTIC ONE NECESSITATES A REVIEW OF THE CURRENT SCIENTIFIC KNOWLEDGE, ADOPTION OF NEW SCIENTIFIC MODELS, AND IDENTIFICATION OF RESEARCH AND KNOWLEDGE GAPS. THE SOSS BROUGHT TOGETHER MULTIDISCIPLINARY STAKEHOLDERS WITH DEEP SCIENTIFIC AND CLINICAL EXPERTISE TO ADDRESS THIS PRESSING NEED.THE THEME OF THE SECOND STATE OF THE SCIENCE SUMMIT, HELD IN 2019 WAS PATHS TO TREATMENT FOR TRAUMATIC BRAIN INJURY(S) WITH A FOCUS ON THE TAXONOMY AND NOSOLOGY OF THE CHRONIC SEQUELAE, CHALLENGES AND OPPORTUNITIES IN CLINICAL PRACTICE AND DEVELOPMENT, AND ETIOLOGY AND MECHANISM OF PERSISTENT SYMPTOMS. AS MEASUREMENT TOOLS ADVANCE, RESEARCH HAS BEEN ABLE TO FOCUS ON DIFFERENT TYPES OF INJURY, BEYOND THE MILD, MODERATE, AND SEVERE CLASSIFICATIONS OF TBI. TO AUGMENT AND SUPPORT THE MANY EFFORTS ACROSS FIELDS AND ORGANIZATIONS OVER THE PAST DECADE, IN 2020 WE WORKED WITH THOUGHT LEADERS ACROSS TBI TO PREPARE A CONSENSUS BLUEPRINT TO DRIVE TRANSLATIONAL SCIENCE FOR TBI. IN 2021, WE PUBLISHED RECOMMENDATIONS IN SUPPORT OF THE NATIONAL TBI PRECISION RESEARCH ROADMAP.IN 2022, WE LAUNCHED THE TBI ACTION ALLIANCE IN SUPPORT OF A NATIONAL TBI PRECISION RESEARCH ROADMAP. THE ROADMAP, BASED ON RECOMMENDATIONS FROM THE BRAIN TRAUMA EXPERT COMMUNITY, OUTLINES A SERIES OF CRITICAL PROJECTS WITH SPECIFIED MILESTONES THAT WILL MATERIALLY ADVANCE PROGRESS TOWARDS THE STATED GOALS OF "ADVANCING A FIRST GENERATION OF TBI DIAGNOSTICS AND TREATMENTS".THE TBI PRECISION RESEARCH ROADMAP FOCUSES ON 7 LINES OF EFFORT:1. INJURY BURDEN: IDENTIFY THE BURDEN OF DISEASE ACROSS ALL POPULATIONS AND INJURY SEVERITIES AS DETERMINED BY INCIDENCE, PREVALENCE AND LONG-TERM TRAJECTORIES OF PATIENTS SUFFERING FROM TBI.2. DISEASE MODELS: DEVELOP AN ARRAY OF TRANSLATIONALLY VALID DISEASE MODELS (PRECLINICAL AND COMPUTATIONAL) BASED ON BIOLOGICAL UNDERSTANDING OF TRAUMA PATHOGENESIS AND DISEASE PHENOTYPES THAT SUPPORT EVALUATION OF NOVEL THERAPIES.3. PRECISION DIAGNOSIS: IDENTIFY, DEVELOP AND VALIDATE DIAGNOSTIC, PROGNOSTIC AND PREDICTIVE BIOMARKERS FORTBI TO DEVELOP FIRST GENERATION DIAGNOSTIC TESTS.4. TARGETED THERAPEUTICS: VALIDATE THERAPEUTIC TARGETS & FAST TRACK A FIRST-GENERATION OF TBI (WELLNESS, DEVICE, DIGITAL, DRUG) THERAPEUTICS TARGETED TO THE RIGHT PERSON AT THE RIGHT TIME.5. CLINICAL PRACTICE IMPLEMENTATION: ACCELERATE ADOPTION OF BEST PRACTICES, CLINICAL PRACTICE GUIDELINES, AND PRECISION THERAPEUTIC APPROACHES TO OPTIMIZE BRAIN HEALTH OUTCOMES.6. TRANSLATIONAL INFRASTRUCTURE AND ENABLINGTECHNOLOGIES: IDENTIFY AND ADDRESS INFRASTRUCTURE,INCENTIVES, REGULATORY AND TECHNOLOGY GAPS TO ADVANCE THE TBI ROADMAP.7. AWARENESS AND ADVOCACY: PLACE TBI AT THE TOP OF THE U.S. PUBLIC POLICY AGENDA AND RAISE AWARENESS TO REDUCE STIGMA OF BRAIN INJURY, ENCOURAGE TREATMENT-SEEKING, AND ENABLE ACCESS AND REIMBURSEMENT OF CARE.IN 2023 WE LAUNCHED THE TBI ACTION ALLIANCE TO SUPPORT THE EXECUTION OF THE NAT
IRS990/ProgSrvcAccomActy3Grp/Desc0STANDARDIZED ADVANCED NEUROIMAGING SCANS ON 3,000 ADULT VOLUNTEERS, THE RESULTING IMAGING DATA, ALONG WITH DEMOGRAPHIC INFORMATION AND THE RESULTS OF NEUROCOGNITIVE ASSESSMENTS, IS FORMING A LIBRARY DOCUMENTING POPULATION VARIATION IN BRAIN STRUCTURE AND FUNCTION AS MEASURED BY THESE ADVANCED IMAGING METHODS.THROUGH THIS IMAGING DATABASE, IT IS OUR GOAL TO ADVANCE NEUROIMAGING TO DRAMATICALLY IMPROVE THE IDENTIFICATION OF AFFECTED INDIVIDUALS AND ALLOW PHYSICIANS TO OBJECTIVELY AND EFFICIENTLY DIAGNOSE CONDITIONS SUCH AS TBI, DEMENTIA AND OTHER BRAIN DISORDERS WHERE BRAIN STRUCTURE IS DETECTED VIA MRI.IN 2022, WE CONTINUED RECRUITMENT INTO THE LIBRARY, REACHING OVER 1,800 ENROLLED SUBJECTS AND ALSO ADDED BLOOD SAMPLE COLLECTION FOR NEWLY RECRUITED INDIVIDUALS. COMPUTATIONAL MODELING & DATA SCIENCES:CVB HAS ESTABLISHED AN INTRAMURAL DATA SCIENCES PROGRAM TO BUILD MACHINE-LEARNING AND ARTIFICIAL INTELLIGENCE BASED PREDICTIVE MODELS OF DISEASE. THESE PROGRAMS BUILD ON OUR ORIGINAL ORION MS BIO-MODELLING PROGRAM AND FOCUSES ON MODELS OF PTSD, TBI, PARKINSONS AND DEMENTIA AND OTHER CONDITIONS.POST-TRAUMATIC STRESS DISORDER ("PSTD") 1.0:OUR MAIN PRIORITY IS TO BUILD A MULTI-MODAL MODEL OF PTSD USING DEEPLY-PHENOTYPED COHORTS SUCH AS THE BEST STUDY AND COHEN VETERANS CENTER STUDIES. IN 2022, WE HAVE BUILT ANALYSIS PIPELINES FOR EPIGENETIC, EEG, INFLAMMATORY MARKER AND CLINICAL DATA AND WE ARE ON TRACK TO BUILD OUR FIRST MODEL BY YEAR END.PARKINSON'S PROGRESSION MARKERS INITIATIVE ("PPMI") DATA SCIENCE MODELING GROUP:EXISTING DIAGNOSES FOR COMPLEX BRAIN DISORDERS SUCH AS PARKINSON'S DISEASE FOCUS ON UNDERSTANDING CLUSTERS OF MAJOR SYMPTOMS. IN ORDER TO DRIVE PROGRESS IN THE DEVELOPMENT OF NEW TREATMENTS, IT IS IMPORTANT TO UNDERSTAND THE ROLE OF SPECIFIC BIOLOGICAL PROCESSES IN DETERMINING PATIENT OUTCOMES. IN THIS PROGRAM, WE MODEL THE MICHAEL J. FOX FOUNDATION ("MJFF") SPONSORED PARKINSON'S PROGRESSION MODEL INITIATIVE STUDY. THE STUDY HAS EVALUATED PARTICIPANTS' CLINICAL STATUS WHILE COLLECTING IMAGING, BEHAVIORAL, 'OMICS AND OTHER ASSESSMENTS LONGITUDINALLY SINCE 2010. IN OUR ALIGNED MISSIONS TO ADVANCE BRAIN HEALTH, MJFF SELECTED CVB'S DATA SCIENCE TEAM TO LEVERAGE THIS COHORT TOGETHER WITH A MULTI-DISCIPLINARY APPROACH TO QUANTITATIVELY EXPLORE, EVALUATE, AND PREDICT DISEASE TRAJECTORY, RISK FACTORS, AND SUBTYPES. GIVEN THE BREADTH AND DEPTH OF THE PPMI DATA AND RICH OPPORTUNITIES TO DEVELOP IMPACTFUL DISEASE MODELS, THE TEAM USE THEIR SUBJECT MATTER EXPERTISE ACROSS TRANSLATIONAL SCIENCE TO GENERATE INSIGHTS FROM 'OMICS, IMAGING, GENETIC AND CLINICAL DATA BY INTEGRATING TECHNIQUES ACROSS ADVANCED STATISTICS, MACHINE LEARNING, AND COMPUTATIONAL MODELING TO FACILITATE PD BIOMARKER DISCOVERY AND DEEPEN OUR UNDERSTANDING OF DISEASE PROGRESSION.MULTIPLE SCLEROSIS ("MS") 1.0:THE ORION BIONETWORKS FLAGSHIP PROGRAM SUCCESSFULLY PILOTED THE ESTABLISHMENT OF A MULTIPLE SCLEROSIS BIONETWORK COMPRISED OF ACADEMIC (NEUROSCIENCE INSTITUTE OF THE BRIGHAM AND WOMEN'S HOSPITAL), ADVOCACY (ACCELERATED CURE PROJECT FOR MS), COMPUTATIONAL (GNS HEALTHCARE, METACELL, THOMSON REUTERS), INFORMATICS (CONVERGE BY DELOITTE, RANCHO BIOSCIENCES, EXAPTIVE), AND ONLINE PATIENT COMMUNITY PARTNERS (PATIENTSLIKEME [PLM]). DE-IDENTIFIED HIPPA-COMPLIANT DATA FROM THREE DATABASES WERE CURATED AND LOADED INTO A CLOUD-BASED DATA KNOWLEDGE MANAGEMENT SYSTEM. THE INTEGRATED REPOSITORY INCLUDES 9,000 SUBJECTS WITH MS AND RELATED CONDITIONS. THE ALLIANCE DEVELOPED A ROADMAP FOR JOINT EXECUTION WITH SPECIFIC SCIENTIFIC AIMS. THE ALLIANCE HAS GENERATED MULTIPLE MODELS BASED ON THE DATA REPOSITORY USING DIFFERENT ALGORITHMIC APPROACHES: PHENOTYPIC PROGNOSTIC MODEL AND TWO MOLECULAR PROGNOSTIC MODELS.PTSD AND TBI PRECLINICAL MODELING PROGRAM:ANIMAL MODELS OF PSYCHIATRIC DISORDERS OFFER A COMPLEMENTARY RESEARCH MODALITY THAT SUPPORTS CLINICAL RESEARCH. IN ORDER TO ACHIEVE A SATISFACTORY DEGREE OF VALIDITY AND RELIABILITY, ANIMAL MODELS OF COMPLEX AND INTRICATE PSYCHIATRIC DI
IRS990/ProgSrvcAccomActyOtherGrp/Desc0FITNESS, IN THIS CONTEXT, IS DEFINED BY THE STAKEHOLDERS, WHO ARE THE SCIENTISTS DIRECTLY INVOLVED IN THE RESEARCH, BUT ALSO THEIR FUNDERS, SPONSORS, PUBLISHERS, RESEARCH TOOL MANUFACTURERS AND COLLABORATION PARTNERS SUCH AS PEERS IN A MULTI-SITE RESEARCH PROJECT. THE ESSENCE OF THE EQIPD QUALITY SYSTEM IS THE SET OF 18 CORE REQUIREMENTS THAT CAN BE ADDRESSED FLEXIBLY, ACCORDING TO USER-SPECIFIC NEEDS AND FOLLOWING A USER-DEFINED TRAJECTORY. THE EQIPD QUALITY SYSTEM PROPOSES GUIDANCE ON EXPECTATIONS FOR QUALITY-RELATED MEASURES, DEFINES CRITERIA FOR ADEQUATE PROCESSES (I.E., PERFORMANCE STANDARDS) AND PROVIDES EXAMPLES OF HOW SUCH MEASURES CAN BE DEVELOPED AND IMPLEMENTED. IN 2023, EQIPD WAS AWARDED A MAJOR GRANT (ISTAND) BY THE INNOVATIVE MEDICINES INITIATIVE IN EUROPE. THERE IS CURRENTLY NO ESTABLISHED FRAMEWORK READILY AVAILABLE OUTSIDE OF SELECTED COMPANIES AND RESEARCH ORGANIZATIONS THAT APPLY INTERNALLY-DEVELOPED STANDARDS AND CRITERIA TO SUPPORT ADEQUATE RESEARCH RIGOR THAT IS COMMENSURATE WITH THE PURPOSE AND APPROPRIATELY ACHIEVABLE. THE GRANT PROGRAM WILL ESTABLISH AND TEST SUCH A FRAMEWORK TO SUPPORT THE PROCESSES OF GENERATING AND REPORTING NONREGULATED RESEARCH RESULTS, AND TO SYSTEMATIZE DECISION-MAKING BASED ON SUCH RESULTS. IT COULD BE APPLIED TO NONREGULATED RESEARCH IN ANY DOMAIN (I.E., RESEARCH NOT CONDUCTED UNDER GOOD PRACTICE GXP STANDARDS SUCH AS GLP), INCLUDING THE DEVELOPMENT OF BIOMARKERS.POLICY & ADVOCACY INITIATIVES:WE ARE COMMITTED TO ADVOCATING FOR POLICY REFORMS AT THE FEDERAL LEVEL THAT BUILD UPON EVIDENCE-BASED PRECISION MEDICINE APPROACHES AND HAVE THE POWER TO BRING NEW SOLUTIONS FOR PTSD AND TBI IN YEARS, NOT DECADES. AS PART OF OUR ADVOCACY EFFORTS, WE CO-FOUNDED THE COALITION TO HEAL INVISIBLE WOUNDS (THE "COALITION"), A COLLABORATIVE INITIATIVE AIMED AT ADVOCATING FOR POLICY REFORMS TO WIDEN AND EXPEDITE THE PIPELINE FOR NEW THERAPIES AND DIAGNOSTICS FOR PTSD AND TBI - WHICH CAN BOTH DRASTICALLY INCREASE THE RISK OF SUICIDE AMONG VETERANS. IN 2023, WE CONTINUE TO GROW MEMBERSHIP IN THE ALLIANCE AS WELL AS CONTRIBUTE TO THE ADVANCEMENT OF SEMINAL LEGISLATION TO SUPPORT VETERANS AND BRAIN RESEARCH.
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt017941055
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0501347
IRS990/PYInvestmentIncomeAmt028608
IRS990/PYOtherExpensesAmt09439104
IRS990/PYOtherRevenueAmt0112735
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0558614
IRS990/PYSalariesCompEmpBnftPaidAmt07547333
IRS990/PYTotalExpensesAmt017523784
IRS990/PYTotalProfFndrsngExpnsAmt036000
IRS990/PYTotalRevenueAmt018082398
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-3997832
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt03831713
IRS990/SavingsAndTempCashInvstGrp/EOYAmt05471810
IRS990ScheduleA/FactsAndCircumstancesTestTxt0COHEN VETERANS BIOSCIENCE, INC. ("CVB") IS A PUBLIC CHARITY BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS. WE ARE LEADING THE WAY TO CURE INVISIBLE WOUNDS FOR THE MILLIONS OF VETERANS, SERVICE MEMBERS, FIRST RESPONDERS, AND CIVILIANS WHO SUFFER FROM TRAUMA-RELATED CONDITIONS, SUCH AS PTSD, TBI AND SUICIDE. GLOBALLY, 2 BILLION INDIVIDUALS ARE DIRECTLY AFFECTED BY BRAIN DISORDERS. THE WORLD HEALTH ORGANIZATION ATTRIBUTES 38% OF THE TOTAL YEARS LOST TO DEATH AND DISABILITY TO BRAIN DISORDERS, A FIGURE WELL AHEAD OF THE NEXT-CLOSEST AND HIGHER-PROFILE DISEASES OF CANCER (12.7%) AND CARDIOVASCULAR DISEASE (11.8%). CVB IS CATALYZING RESEARCH TO ADVANCE BRAIN HEALTH AT ALL STAGES OF SCIENTIFIC DISCOVERY-FROM THEORY TO THERAPEUTIC.THIS MEMO PROVIDES EVIDENCE OF QUANTITATIVE AND QUALITATIVE MEASURES WHICH SUPPORT CONTINUED PUBLIC CHARITY STATUS. CVB MET THE QUANTITATIVE PERCENTAGE TEST CRITERION FOR SUPPORTING FACTS AND CIRCUMSTANCES IN FY23. CVB ENGAGES WITH AND MAKES AVAILABLE TO RESEARCHERS, POLICY MAKERS, AND THE GENERAL PUBLIC A BROAD ARRAY OF PROGRAMS, TOOLS, SERVICES, AND INFORMATION WHICH ADVANCE THE STATE OF BRAIN SCIENCE, GUIDED BY AN INDEPENDENT BOARD AND ADVISORY COUNSELS IN CONJUNCTION WITH CVB'S RENOWNED EXPERTS IN RELEVANT FIELDS OF NEUROSCIENCE, DATA SCIENCE AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT. FOLLOWING ARE MORE DETAILED EVIDENCE OF THESE FACTS AND CIRCUMSTANCES. COHEN VETERANS BIOSCIENCE, INC. EARLY ORIGINS WERE AS AN ORGANIZATION UNDER THE FISCAL SPONSORSHIP OF THE MARIN COUNTY COMMUNITY FOUNDATION, LATER ESTABLISHED AS A STAND-ALONE 501(C)3 IN 2014 UNDER THE NAME ORION BIONETWORKS. CVB'S FOUNDER AND CEO HAS A PERSONAL CONNECTION TO THE PUBLIC WORK THE ORGANIZATION CARRIES OUT BY VIRTUE OF HER HUSBAND BEING A VETERAN OF THE US AIRFORCE SERVICE AND HER SISTER SERVING AS AN AIRFORCE COLONEL, WITH ACTIVE DEPLOYMENTS TO OEF/OIF. THE FORMAL NAME CHANGE TO COHEN VETERANS BIOSCIENCE TOOK PLACE IN 2015 IN CONCERT WITH GENEROUS SEED FUNDING FROM STEVEN A. COHEN. CVB QUALIFIES AS A PUBLIC CHARITY UNDER THE "FACTS AND CIRCUMSTANCES" TEST OF 1.170A-9(F)(3) OF THE TREASURY REGULATIONS, BASED UPON THE FOLLOWING:CVB IS ORGANIZED AND OPERATED SO AS TO ATTRACT NEW AND ADDITIONAL FUNDING ON A CONTINUOUS AND BONA FIDE BASIS; CVB'S CURRENT FUNDRAISING PLANS ARE TARGETED AT A BROAD BASE OF DONORS, INCLUDING FOUNDATIONS, INDIVIDUALS, AND GOVERNMENT AGENCIES. - ONLINE GIVING: CVB HAS HAD A DONATION BUTTON ON ITS WEBSITE AND ALL SOCIAL MEDIA SINCE INCEPTION. AS OF FY22, WE ESTABLISHED REGISTERED STATUS ACROSS ALL 50 STATES. THE ORGANIZATION RUNS SEVERAL ONLINE DONATION CAMPAIGNS THROUGHOUT THE YEAR (E.G. MEMORIAL DAY, VETERANS DAY, GIVING DAY). -FUNDRAISING EVENTS: WE CONTINUE TO GROW OUR REACH TO THE GENERAL PUBLIC THROUGH FUNDRAISING EVENTS, SOME SPONSORED DIRECTLY AND OTHERS ON OUR BEHALF THROUGH OUR AMBASSADOR'S PROGRAM AND ALSO A CROWDRISE CAMPAIGN CAPABILITY WE ADDED TO OUR WEBSITE IN FY23. STARTING IN 2020, WE ENGAGED IN PARTNERSHIPS WITH VETERANS SERVICE ORGANIZATIONS WHO HAVE COMMITTED TO RAISE AWARENESS OF INDIVIDUALLY DRIVEN FUNDRAISING CAMPAIGNS FOR VETERANS PTSD, TBI AND SUICIDE.-MEMBERSHIP PROGRAMS: -IN 2022, WE LAUNCHED AN ANNUAL MEMBERSHIP PROGRAM WITH OTHER NONPROFIT FOUNDATIONS, UNDER OUR COALITION TO HEAL INVISIBLE WOUNDS, TO SUPPORT ADVOCACY AND EDUCATION INITIATIVES. -IN 2023, WE LAUNCHED THE TBI ACTION ALLIANCE PROGRAM WHICH INCLUDES BOTH MEMBERSHIP AND SPONSORSHIP OPPORTUNITIES FOR INDIVIDUALS, PROFESSIONALS, AND INSTITUTIONS TO SUPPORT OUR RESEARCH PROGRAMS TO ADVANCE DIAGNOSTICS AND THERAPEUTICS FOR TRAUMATIC BRAIN INJURIES (TBI). WE HAVE OVER 50 MEMBERS AND INSTITUTIONS ENROLLED TO DATE.-GOVERNMENT & FOUNDATION RESEARCH GRANTS: CVB HAS RECEIVED SUPPORT US GOVERNMENT AGENCIES SUCH AS THE NATIONAL INSTITUTES OF HEALTH AND THE DEPARTMENT OF DEFENSE; A NUMBER OF NONPROFIT ORGANIZATIONS AND FOUNDATIONS INTEREST
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0HRA FORFEITURES - 2020 AMOUNT: $ 28,475. STIMULUS/COVID CREDITS - 2020 AMOUNT: $ 3,629. 2021 AMOUNT: $ 2,480. OTHER REFUNDS - 2021 AMOUNT: $ 110,255. OTHER INCOME - 2022 AMOUNT: $ 37,205. GRANT REFUNDS - 2022 AMOUNT: $ 326,982.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt1DR. HAAS HAS OVER 20 YEARS OF PHARMACEUTICAL EXECUTIVE AND CLINICAL RESEARCH EXPERIENCE INCLUDING DEVELOPMENT LEADERSHIP ROLES IN MEDICAL MARKETING, FULL CLINICAL DEVELOPMENT, EARLY DEVELOPMENT, AND TRANSLATIONAL AND BIOMARKER SCIENCES IN PSYCHIATRY AND NEUROLOGY. DURING HER TENURE AT JOHNSON & JOHNSON, SHE SUCCESSFULLY FILED NDAS IN THE US AND EUROPE FOR RISPERIDONE INDICATIONS IN AUTISM, ADOLESCENT SCHIZOPHRENIA, JUVENILE BIPOLAR DISORDER AND CONDUCT DISORDERS. SHE ALSO LED DEVELOPMENT TEAMS EVALUATING COMPOUNDS FOR DEPRESSION, NEUROPATHIC PAIN, EPILEPSY, AND MIGRAINE DISORDER. SHE SERVED 3 YEARS AS CHIEF SCIENCE AND TECHNOLOGY OFFICER FOR ONE MIND FOR RESEARCH, A NONPROFIT ORGANIZATION LAUNCHED IN MAY 2012 BY PATRICK J KENNEDY. SHE ORCHESTRATED THE LAUNCH OF ONE MIND'S SEMINAL PROGRAMS, APOLLO, AN INFORMATICS RESEARCH PORTAL AND, GEMINI, AN INTERNATIONAL TBI/PTSD RESEARCH PROGRAM. AS AN "INTRAPRENEUR" AT J&J SHE ESTABLISHED THE FIRST NEUROSCIENCE TRANSLATIONAL MEDICINE & INTEGRATIVE SOLUTIONS DEPARTMENT, AND CO-FOUNDED THE FIRST COMPANION DIAGNOSTICS CENTER OF EXCELLENCE AS WELL AS J&J'S HEALTHCARE INNOVATION TEAM. SHE SERVES ON SEVERAL ADVISORY BOARDS INCLUDING ALTO NEUROSCIENCE, KREMBIL CENTRE FOR NEUROINFORMATICS, VIRTUALBRAINCLOUD, PARTNERSHIP FOR ASSESSMENT AND ACCREDITATION OF SCIENTIFIC PRACTICE (PAASP) AND INTERUNIVERSITY MICROELECTRONICS CENTRE (IMEC) AN INTERNATIONAL RESEARCH & DEVELOPMENT AND INNOVATION HUB. DR. HAAS EARNED HER BS IN BIOENGINEERING FROM THE UNIVERSITY OF PENNSYLVANIA, AN MS IN BIOMEDICAL ENGINEERING FROM RUTGERS UNIVERSITY, NEW JERSEY, AND HER MD PHD WITH DISTINCTION IN NEUROSCIENCE FROM ALBERT EINSTEIN COLLEGE OF MEDICINE, NEW YORK. BOARD MEMBER, SECRETARY, THERESA FRANGIOSA HAS EXTENSIVE EXECUTIVE EXPERIENCED BASED ON HER 25 YEAR CAREER WITH THE PHARMACEUTICAL SECTOR. IN HER ROLES WITHIN PHARMA, SHE WAS A GLOBAL LAUNCH LEADER AS WELL AS OVERSEEING EARLY COMMERCIAL STRATEGY IN NEUROSCIENCES. SHE LED LARGE SCALE TEAMS, CROSS-FUNCTIONAL TEAMS TO DEFINE DISEASE AND THERAPEUTIC AREA STRATEGIES FOR JANSSEN AND GLAXOSMITHKLINE. SHE HAS ALSO LED INDICATION PRIORITIZATION EFFORTS AND DEVELOPMENT OF OVER 200 TARGET PRODUCT PROFILES OVER A VARIETY OF DISEASE STATES, LEVERAGING WELL-ESTABLISHED PROCESSES AND FRAMEWORKS, INCLUDING DEEPER UNDERSTANDING OF PATIENT JOURNEYS TO CREATE KEY INSIGHTS. SHE HAS APPLIED HER PROFESSIONAL CAREER EXPERIENCE AND HER PASSION FOR ADVOCACY TO HELP CREATE A CHANNEL FOR FEEDBACK FROM THOSE DIAGNOSED WITH OR AT RISK FOR ALZHEIMER'S DISEASE OR DEMENTIA, THEIR CARE PARTNERS AND INDIVIDUALS WHO ARE 'WORRIED WELL', CALLED THE A-LIST. SHE IS THE LEAD INVESTIGATOR FOR THIS RESEARCH STUDY WITH IRB OVERSIGHT. MS. FRANGIOSA OBTAINED HER BACHELOR OF ADMINISTRATION, ACCOUNTING CONCENTRATION FROM URSINUS COLLEGE (COLLEGEVILLE, PA) IN 1988 AND HER MASTERS OF BUSINESS ADMINISTRATION, PHARMACEUTICAL MARKETING FROM ST. JOSEPH'S UNIVERSITY IN 1996. BOARD MEMBER, TREASURER, MICHAEL C. SULLIVAN IS THE CHIEF OF STAFF AND HEAD OF EXTERNAL AFFAIRS OF POINT72 ASSET MANAGEMENT. MR. SULLIVAN PREVIOUSLY SERVED AS A SENIOR AIDE IN THE UNITED STATES SENATE, FOCUSING ON TELECOM, TECHNOLOGY, AND FINANCE ISSUES. MR. SULLIVAN ALSO SERVED AS A STAFF MEMBER IN THE U.S. HOUSE OF REPRESENTATIVES WORKING ON SIMILAR ISSUES. BEFORE COMING TO CAPITOL HILL, MR. SULLIVAN WAS THE HEAD OF STRATEGIC DEVELOPMENT FOR A TELECOMMUNICATIONS FOCUSED TRADE ASSOCIATION. MR. SULLIVAN IS INVOLVED WITH SEVERAL VETERANS' MENTAL HEALTH-RELATED NONPROFIT ORGANIZATIONS. HE HELPED ESTABLISH AND SERVES ON THE BOARD AND AS TREASURER OF THE COHEN VETERANS NETWORK, WHICH OPERATES A NATIONAL NETWORK OF CLINICS TO TREAT VETERANS AND THEIR FAMILY MEMBERS AFFECTED BY POST-TRAUMATIC STRESS. MR. SULLIVAN IS AN ASSOCIATE AT THE NYU-STERN ENDLESS FRONTIER LABS, WHERE HE MENTORS START-UP COMPANIES IN ARTIFICIAL INTELLIGENCE, MACHINE LEARNING, AND RELATED FIELDS. HE IS ALSO A MEMBER OF THE EXECUTIVE COMMITTEE OF STUDENTS FIRST NEW YORK, A NONPROFIT O
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc1PART II SECT C LINE 17A FACTS & CIRCUMSTANCES TEST (CONT):
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt010755381
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt017941055
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt016160581
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt016316026
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt020795052
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt081968095
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0223966
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt028608
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt059585
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0154639
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt098872
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0565670
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt0364187
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt0112735
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt032104

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.84$0.10$1.74$3.37$1.38$1.99
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.08$3.11$0.03$8.38$14.1$5.70
2023Detailed filing. Detailed filing data is available for this year.$11.7$3.85$7.89$11.3$15.3$4.00
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$15.6$3.70$11.9$18.1$17.5$0.56
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$18.0$6.83$11.1$16.3$18.1$1.86
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$18.9$8.43$10.4$16.5$18.2$1.69
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$24.2$13.0$11.2$21.0$20.2$0.87
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$16.4$6.02$10.3$16.8$14.8$2.05
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$14.9$6.58$8.28$4.37$11.3$6.97
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$25.4$10.2$15.3$31.4$16.3$15.1
2015Detailed filing. Detailed filing data is available for this year.$0.45$0.33$0.12$0.07$0.65$0.58
Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2023 filings • 501(c)3 • $10M-$25M nonprofits